Filters
Federal Administrative Court on the Delineation between Substance-Based Medical Devices and Medicinal Products
Dr Carolin Monsees and Dr Michael Beer appointed equity partners
Revision of energy efficiency requirements for data centres: an overview of the amendment to the Energy Efficiency Act
Complex rules, clear solutions: Your packaging compliance from a single source
Federal Court of Justice Ruling on Public Advertising for Medical Cannabis on Online Platforms
Hamburg Regional Court: validity of the presumption of availability in maintenance contracts
Online coaching and distance learning: Federal Court of Justice clarifies application of the Distance Learning Protection Act
Impact of the new Biotech Act on Clinical Trials in the EU
A European Perspective #1 | EU Biotech Act: Faster Clinical Trial Approvals Ahead | The European Commission’s proposed Biotech Act aims to streamline clinical trial procedures, shorten approval timelines, and harmonise data protection rules across the EU. If adopted, the reform could significantly accelerate multinational clinical research in the EU.
4 of 9 Insights
The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU
A European Perspective #1 | The EU’s largest pharmaceutical law reform in over 20 years introduces a new regulatory exclusivity framework, revised orphan drug incentives and an antimicrobial voucher. Strategic exclusivity planning will become essential for pharmaceutical companies.
1 of 9 Insights
